Bank of Montreal
NGM

Bank of Montreal’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bank of Montreal’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-771
Closed -$20K – 5135
2021
Q1 		$20K Sell
771
-2,900
-79% -$81.2K ﹤0.01% 4071
2020
Q4 		$98K Buy
3,671
+2,567
+233% +$56.2K ﹤0.01% 3602
2020
Q3 		$18K Sell
1,104
-777
-41% -$14.2K ﹤0.01% 3890
2020
Q2 		$36K Buy
1,881
+1,065
+131% +$20.4K ﹤0.01% 3591
2020
Q1 		$10K Sell
816
-2,256
-73% -$36.8K ﹤0.01% 3495
2019
Q4 		$57K Buy
3,072
+2,473
+413% +$36.2K ﹤0.01% 3789
2019
Q3 		$8K Buy
599
+48
+9% +$720 ﹤0.01% 4489
2019
Q2 		$8K Buy
+551
New +$8.06K ﹤0.01% 4605

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GA
Greenspring Associates Owings Mills, Maryland $1.48B AUM 61.93% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Bank of Montreal's NGM Position: Q2 2021 in Review

Bank of Montreal sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2021, closing a stake of 771 shares — an estimated $20K sold.

Bank of Montreal first reported a position in NGM in Q2 2019 and held it in 8 quarters. The position peaked at $98K in Q4 2020. 107 funds tracked by Wall St. Rank hold NGM as of Q2 2021.

  • Bank of Montreal reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 771 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $20K.
  • Bank of Montreal first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $98K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.